Background. Surgical resection of lung cancer remains the treatment of choice in
appropriately staged disease, but conventional imaging techniques have limitations …

BACKGROUND Successful treatment of nonsmall cell lung carcinoma (NSCLC) with radical
radiotherapy (RT) requires accurate delineation of tumor extent. Conventional computed …

OBJECTIVE. We determined the prognostic value of 18F-fluorodeoxyglucose (FDG) positron
emission tomography (PET) for patients with treated lung cancer. MATERIALS AND …

OBJECTIVE: We sought to predict lymph node metastasis and tumor invasiveness in clinical
T1 N0 M0 lung adenocarcinomas, and we measured fluorodeoxyglucose uptake on positron …

Introduction Previous studies have shown that lung squamous cell carcinoma has higher 18
F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) than …

Objective: Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG), a
glucose analogue, as a metabolic tumour marker, has been proposed for the non-invasive …

OBJECTIVE: Bronchioloalveolar carcinoma is a clinically heterogeneous subtype of non–
small cell lung carcinoma that frequently has low 2-[18F] fluoro-d-glucose (FDG) uptake on …

Purpose The aims were to determine if the maximum standardized uptake value (SUV max)
of the primary tumor as determined by preoperative 18 F-fluoro-2-deoxyglucose (18 F-FDG) …

Positron emission tomography (PET) using fluorine-18 deoxyglucose (FDG), showing
increased FDG uptake and retention in malignant cells, has been proven useful to …

Objective: Positron emission tomography (PET), when used with the intravenously
administered radiopharmaceutical F-18 fluorodeoxyglucose (FDG), has the potential to help …